Whitepaper/App Note

Whitepaper: Understanding the links between drug delivery route and in vitro test methods

Posted: 7 December 2016 | | 4 comments

In this whitepaper, Copley Scientific review drug product characteristics that define the success of delivery via any given route, and the tests used to measure them…

In vitro tests are widely used, from R&D through to QC, to improve the efficacy of drug delivery and confirm product consistency. Ensuring a drug reaches its intended site of action in vivo, in an appropriate state, is a crucial first step towards meeting clinical performance goals.

Drugs may be delivered by the gastrointestinal tract; or via the rectal and vaginal mucosal membranes; through the surface of the skin; or by inhalation via the nose or lungs. In each case the requirements for effective delivery are different and the tests applied to assess drug performance differ accordingly.

In this introductory white paper we review the drug product characteristics that define the success of delivery via any given route, and the tests used to measure them. A key focus is the link between the mechanisms of drug delivery and the test conditions applied.

 

This whitepaper is restricted - login or subscribe free to access

epr 3 2018 magazine coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Related organisations

4 responses to “Whitepaper: Understanding the links between drug delivery route and in vitro test methods”

  1. alejandro says:

    Please send me the full whitepaper, I´m already subscribed.
    Thanks

    • Nicholas Jackson says:

      Hi Alejandro, if you are already a member then you simply have to login to access the whitepaper. If you are having problems logging in please let us know.

  2. Yuri Drygin says:

    Please register and give me access to the rest of the paper.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend